Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine

Journal of Experimental Biology

Volumn 206, Issue 21, 2003, Pages 3803-3808

  Luke, Thomas C ^a   Hoffman, Stephen L ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b SANARIA INC   (United States)

Author keywords

Immunization; Irradiated sporozoite; Malaria vaccine; Plasmodium falciparum; Radiation attenuated sporozoite

Indexed keywords

ANIMALS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; SPOROZOITES; VACCINATION; VACCINES, ATTENUATED;

PLASMODIUM FALCIPARUM;

EID: 0242658694     PISSN: 00220949     EISSN: None     Source Type: Journal    
DOI: 10.1242/jeb.00644     Document Type: Review

References (49)

1. Baird, J. K., Owusu, A. S., Utz, G. C., Koram, K., Barcus, M. J., Jones, T. R., Fryauff, D. J., Binka, F. N., Hoffman, S. L. and Nkrumah, F. N. (2002). Seasonal malaria attack rates in infants and young children in northern Ghana. Am. J. Trop. Med. Hyg. 66, 280-286.
2. Ballou, W. R., Hoffman, S. L., Sherwood, J. A., Hollingdale, M. R., Neva, F. A., Hockmeyer, W. T. and Gordon, D. M. (1987). Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1, 1277-1281.
3. Beier, J. C., Davis, J. R., Vaughan, J. A., Noden, B. H. and Beier, M. S. (1991). Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles Stephensi. Am. J. Trop. Med. Hyg. 44, 564-570.
4. Beier, J. C., Oster, C. N., Onyango, F. K., Bales, J. D., Sherwood, J. A., Perkins, P. V., Chumo, D. K., Koech, D. V., Whitmire, R. E., Roberts, C. R. et al. (1994). Plasmodium falciparum incidence relative to entomologie inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am. J. Trop. Med. Hyg. 50, 529-536.
5. Bojang, K. A., Milligan, P. J., Pinder, M., Vigneron, L., Allouche, A., Kester, K. E., Ballou, W. R., Conway, D. J. and Reece, W. H. (2001). Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358, 1927-1934.
6. Campbell, C. C., Collins, W. E., Nguyen-Dinh, P., Barber, A. and Broderson, J. R. (1982). Plasmodium falciparum gametocytes from culture in vitro develop to sporozoites that are infectious to primates. Science 217, 1048-1050.
7. Chulay, J. D., Schneider, I., Cosgriff, T. M., Hoffman, S. L., Ballou, W. R., Ouakyi, I. A., Carter, R., Trosper, J. H. and Hockmeyer, W. T. (1986). Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. Am. J. Trop. Med. Hyg. 35, 66-68.
8. Church, L. W., Le, T. P., Bryan, J. P., Gordon, D. M., Edelman, R., Fries, L., Davis, J. R., Herrington, D. A., Clyde, D. F., Shmuklarsky, M. J. et al. (1997). Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J. Infect. Dis. 175, 915-920.
9. Clyde, D. F. (1990). Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75. Bull WHO 68, 9-12.
10. Clyde, D. F., McCarthy, V. C., Miller, R. M. and Hornick, R. B. (1973b). Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266, 398-401.
11. Clyde, D. F., McCarthy, V. C., Miller, R. M. and Woodward, W. E. (1975). Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg. 24, 397-401.
12. Clyde, D. F., Most, H., McCarthy, V. C. and Vanderberg, J. P. (1973a). Immunization of man against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266, 169-177.
13. Dame, J. B., Williams, J. L., McCutchan, T. F., Weber, J. L., Wirtz, R. A., Hockmeyer, W. T., Maloy, W. L., Haynes, J. D., Schneider, I., Roberts, D. et al. (1984). Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225, 593-599.
14. Doolan, D. L., Hoffman, S. L., Southwood, S., Wentworth, P. A., Sidney, J., Chestnut, R. W., Keogh, E., Apella, E., Nutman, T. B., Lal, A. A. et al. (1997). Degenerate cytotoxic T cell epitopes from P. falciparum restricted by HLA-A and HLA-B supertypes alleles. Immunity 7, 97-112.
15. Doolan, D. L., Southwood, S., Chesnut, R., Appella, E., Gomez, E., Richards, A., Higashimoto, Y. I., Maewal, A., Sidney, J., Gramzinski, R. A. et al. (2000). HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J. Immunol. 165, 1123-1137.
16. Edelman, R., Hoffman, S. L., Davis, J. R., Beier, M., Sztein, M. B., Losonsky, G., Herrington, D. A., Eddy, H. A., Hollingdale, M. R., Gordon, D. M. et al. (1993). Long-term persistence of sterile immunity in a volunteer immunized with X-Irradiated Plasmodium falciparum sporozoites. J. Infect. Dis. 168, 1066-1070.
17. Egan, J. E., Hoffman, S. L., Haynes, J. D., Sadoff, J. C., Schneider, I., Grau, G. E., Hollingdale, M. R., Ballou, W. R. and Gordon, D. M. (1993). Humoral immune responses in volunteers immunized with Irradiated Plasmodium falciparum sporozoites. Am. J. Trop. Med. Hyg. 49, 166-173.
18. Hale, B. R and Hoffman, S. L. (2003). A randomized, double-blind, placebo-controlled dose ranging trial of tafenaquine for weekly prophylaxis against Plasmodium falciparum. Clin. Infect. Dis. 36, 541-549.
19. Haynes, J. D., Diggs, C. L., Hines, F. A. and Desjardins, R. E. (1976). Culture of human malaria parasites Plasmodium falciparum. Nature 263, 767-769.
20. Herrington, D. A., Clyde, D. F., Losonsky, G., Cortesia, M., Murphy, J. R., Davis, J., Bager, S. and Felix, A. M. (1987). Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature 328, 257-259.
21. Herrington, D., Davis, J., Nardin, E., Beier, M., Cortese, J., Eddy, H., Losonsky, G., Hollingdale, M., Sztein, M., Levine, M. et al. (1991). Successful immunization of humans with Irradiated sporozoites: humoral and cellular responses of the protected individuals. Am. J. Trop. Med. Hyg. 45, 539-547.
22. Hilleman, M. R. (1987). Yeast recombinant hepatitis B vaccine. Infection 15, 3-7.
23. Huffman, S. L. (1997). Experimental challenge of volunteers with malaria. Ann. Intern. Med. 127, 233-235.
24. Hoffman, S. L. and Miller, L. H. (1996). Perspectives on malaria vaccine development. In Malaria Vaccine Development: A Multi-Immune Response Approach (ed. S. L. Hoffman), pp. 1-13. Washington, DC: ASM Press.
25. Hoffman, S. L., Franke, E. D., Hollingdale, M. R. and Druilhe, P. (1996). Attacking the infected hepatocyte. In Malaria Vaccine Development: A Multi-Immune Response Approach (ed. S. L. Hoffman), pp. 35-75. Washington, DC: ASM Press.
26. Hoffman, S. L., Goh, L. M., Luke, T. C., Schneider, I., Le, T. P., Doolan, D. L., Sacci, J., de la Vega, P., Dowler, M., Paul, C. et al. (2002). Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect. Dis. 185, 1155-1164.
27. Hoffman, S. L., Oster, C. N., Plowe, C. V., Woollett, G. R., Beier, J. C., Chulay, J. D., Wirtz, R. A., Hollingdale, M. R. and Mugambi, M. (1987). Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science 237, 639-642.
28. Kester, K. E., McKinney, D. A., Tornieporth, N., Ockenhouse, C. F., Heppner, D. G., Hall, T., Krzych, U., Delchambre, M., Voss, G., Dowler, M. G. et al. (2001). Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J. Infect. Dis. 183, 640-647.
29. Krzych, U., Lyon, J. A., Jareed, T., Schneider, I., Hollingdale, M. R., Gordon, D. M. and Ballou, W. R. (1995). T lymphocytes from volunteers immunized with Irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. J. Immunol. 155, 4072-4077.
30. Long, C. A. and Hoffman, S. L. (2002). Parasitology: malaria - from infants to genomics to vaccines. Science 297, 345-347.
31. Malik, A., Egan, J. E., Houghten, R. A., Sadoff, J. C. and Hoffman, S. L. (1991). Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc. Natl. Acad. Sci. USA 88, 3300-3304.
32. McCarthy, V. C. and Clyde, D. F. (1977). Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-induced protective immunity in man. Exp. Parasitol. 41, 167-171.
33. Moreno, A., Clavijo, P., Edelman, R., Davis, J., Sztein, M., Herrington, D. and Nardin, E. (1991). Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. Int. Immunol. 3, 997-1003.
34. Moreno, A., Clavijo, P., Edelman, R., Davis, J., Sztein, M., Sinigaglia, F. and Nardin, E. (1993). CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. J. Immunol. 151, 489-499.
35. Nardin, E. H. (1990). T cell responses in a sporozoite-immunized human volunteer and a chimpanzee. Immunol. Lett. 25, 43-48.
36. Nardin, E. H., Herrington, D. A., Davis, J., Levine, M., Stuber, D., Takacs, B., Caspers, P., Barr, P., Altszuler, R., Clavijo, P. et al. (1989). Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer. Science 246, 1603-1606.
37. Nardin, E. H., Nussenzweig, R. S., Altszuler, R., Herrington, D., Levine, M., Murphy, J., Davis, J., Bathurst, I., Barr, P., Romero, P. et al. (1990). Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers. Bull. WHO 68, 85-87.
38. Nussenzweig, R. S., Vanderberg, J., Most, H. and Orton, C. (1967). Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 216, 160-162.
39. Nussenzweig, V. and Nussenzweig, R. S. (1989). Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 45, 283-334.
40. Owusu-Agyei, S., Koram, K. A., Baird, J. K., Utz, G. C., Binka, F. N., Nkrumah, F. K., Fryauff, D. J. and Hoffman, S. L. (2001). Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. Am. J. Trop. Med. Hyg. 65, 197-203.
41. Richie, T. L. and Saul, A. (2000). Progress and challenges for malaria vaccines. Nature 415, 694-701.
42. Rieckmann, K. H. (1990). Human immunization with attenuated sporozoites. Bull WHO 68, 13-16.
43. Rieckmann, K. H., Beaudoin, R. L., Cassells, J. S. and Sell, D. W. (1979). Use of attenuated, sporozoites in the immunization of human volunteers against falciparum malaria. Bull WHO 57, 261-265.
44. Rieckmann, K. H., Carson, P. E., Beaudoin, R. L., Cassells, J. S. and Sell, K. W. (1974). Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 68, 258-259.
45. Stoute, J. A., Kester, K. E., Krzych, U., Wellde, B. T., Hall, T., White, K., Glenn, G., Ockenhouse, C. F., Garcon, N., Schwenk, R. et al. (1998). Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J. Infect. Dis. 178, 1139-1144.
46. Trager, W. and Jensen, J. B. (1976). Human malaria parasites in continuous culture. Science 193, 673-675.
47. Wizel, B., Houghten, R. A., Parker, K., Coligan, J. E., Church, P., Gordon, D. M., Ballou, W. R. and Hoffman, S. L. (1995a). Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum surface sporozoite protein 2. J. Exp. Med. 182, 1435-1445.
48. Wizel, B., Houghten, R., Church, P., Tine, J. A., Lanar, D. E., Gordon, D. M., Ballou, W. R., Sette, A. and Hoffman, S. L. (1995b). HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. J. Immunol. 155, 766-775.
49. Yoshida, N., Nussenzweig, R. S., Potocnjak, P., Nussenzweig, V. and Aikawa, M. (1980). Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science 207, 71-73.